• Citer

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

par Ducreux, Michel;Van Cutsem, Eric;Van Laethem, Jean-Luc ;Gress, T M;Jeziorski, K;Rougier, Philippe;Wagener, Theo;Anak, Özlem;Baron, Benoît;Nordlinger, Bernard;EORTC Gastro Intestinal Tract Cancer Group,
Référence European journal of cancer, 41, 3, page (398-403)
Publication Publié, 2005-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Auteur:	Ducreux, Michel; Van Cutsem, Eric; Van Laethem, Jean-Luc; Gress, T M; Jeziorski, K; Rougier, Philippe; Wagener, Theo; Anak, Özlem; Baron, Benoît; Nordlinger, Bernard; EORTC Gastro Intestinal Tract Cancer Group,
Informations sur la publication:	European journal of cancer, 41, 3, page (398-403)
Statut de publication:	Publié, 2005-02
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	5-Fluorouracil
	Biliary tract carcinoma
	Cisplatin
	Phase II
	Survival
	Toxicity
MeSH keywords:	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Biliary Tract Neoplasms -- drug therapy
	Cisplatin -- administration & dosage
	Disease Progression
	Female
	Fluorouracil -- administration & dosage
	Humans
	Leucovorin -- administration & dosage
	Male
	Middle Aged
	Risk Factors
	Survival Analysis
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2004.10.026
	info:pii/S0959-8049(04)00972-4
	info:scp/19944433180
	info:pmid/15691639